Iag Wealth Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Iag Wealth Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $8,850 - $11,172	50 New	50 $11,000
Q2 2021 Aug 04, 2021	SELL	$187.49 - $221.1 $0 - $0	0 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$207.02 - $241.31 $0 - $0	0 New	0 $0
Q3 2020 Feb 11, 2021	SELL	$255.65 - $303.1 $1,278 - $1,515	-5 Closed	0 $0
Q4 2019 Feb 11, 2021	BUY	$166.71 - $223.91 $833 - $1,119	5 New	5 $2,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Iag Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Iag Wealth Partners, LLC with notifications on news.